Das P - Search Results

1

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease.

Born HA, Kim JY, Savjani RR, Das P, Dabaghian YA, Guo Q, Yoo JW, Schuler DR, Cirrito JR, Zheng H, Golde TE, Noebels JL, Jankowsky JL. Born HA, et al. Among authors: das p. J Neurosci. 2014 Mar 12;34(11):3826-40. doi: 10.1523/JNEUROSCI.5171-13.2014. J Neurosci. 2014. PMID: 24623762 Free PMC article.

2

Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.

Das P, Howard V, Loosbrock N, Dickson D, Murphy MP, Golde TE. Das P, et al. J Neurosci. 2003 Sep 17;23(24):8532-8. doi: 10.1523/JNEUROSCI.23-24-08532.2003. J Neurosci. 2003. PMID: 13679422 Free PMC article.

3

Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice.

Levites Y, Jansen K, Smithson LA, Dakin R, Holloway VM, Das P, Golde TE. Levites Y, et al. Among authors: das p. J Neurosci. 2006 Nov 15;26(46):11923-8. doi: 10.1523/JNEUROSCI.2795-06.2006. J Neurosci. 2006. PMID: 17108166 Free PMC article.

4

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy.

Wang A, Das P, Switzer RC 3rd, Golde TE, Jankowsky JL. Wang A, et al. Among authors: das p. J Neurosci. 2011 Mar 16;31(11):4124-36. doi: 10.1523/JNEUROSCI.5077-10.2011. J Neurosci. 2011. PMID: 21411653 Free PMC article.

5

Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult.

Rodgers SP, Born HA, Das P, Jankowsky JL. Rodgers SP, et al. Among authors: das p. Mol Neurodegener. 2012 Jun 18;7:28. doi: 10.1186/1750-1326-7-28. Mol Neurodegener. 2012. PMID: 22709352 Free PMC article.

6

Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice.

Chiang ACA, Fowler SW, Savjani RR, Hilsenbeck SG, Wallace CE, Cirrito JR, Das P, Jankowsky JL. Chiang ACA, et al. Among authors: das p. J Exp Med. 2018 May 7;215(5):1349-1364. doi: 10.1084/jem.20171484. Epub 2018 Apr 6. J Exp Med. 2018. PMID: 29626114 Free PMC article.

7

Open peer commentary regarding Abeta immunization and CNS inflammation by Pasinetti et al.

Das P, Golde TE. Das P, et al. Neurobiol Aging. 2002 Sep-Oct;23(5):671-4; discussion 683-4. doi: 10.1016/s0197-4580(02)00031-3. Neurobiol Aging. 2002. PMID: 12392769 Review. No abstract available.

8

Anti-Abeta42- and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model.

Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE. Levites Y, et al. Among authors: das p. J Clin Invest. 2006 Jan;116(1):193-201. doi: 10.1172/JCI25410. Epub 2005 Dec 8. J Clin Invest. 2006. PMID: 16341263 Free PMC article.

9

Dysfunction of TGF-beta signaling in Alzheimer's disease.

Das P, Golde T. Das P, et al. J Clin Invest. 2006 Nov;116(11):2855-7. doi: 10.1172/JCI30284. J Clin Invest. 2006. PMID: 17080189 Free PMC article.

10

Quantitative and mechanistic studies of Abeta immunotherapy.

Golde TE, Das P, Levites Y. Golde TE, et al. Among authors: das p. CNS Neurol Disord Drug Targets. 2009 Mar;8(1):31-49. doi: 10.2174/187152709787601830. CNS Neurol Disord Drug Targets. 2009. PMID: 19275635 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,675 results

Search Page

Filters